Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Diagnostic Immunohistochemistry: Current Applications and Future Directions

Sabariah Rahman, and Leong, Anthony S.Y., (1991) Diagnostic Immunohistochemistry: Current Applications and Future Directions. Malaysian Journal of Pathology, 13 (1). pp. 17-28. ISSN 0126-8635

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
400Kb

Official URL: http://www.mjpath.org.my/past_issue/MJP1991.1/diagnostic%20immunohistochemistry.pdf

Affiliations

Unlversltl Salns Malaysia, Dept. of Pathology
Institute of Medical & Veterinary Science, Adelaide, South Australia. Division of Tissue Pathology

Abstract

In this review, the applications of enzyme immunohistochemistry in diagnostic pathologj are discussed. Antibodies for diagnostic use are grouped into eight categories, viz, antibodies for tumour typing, for lymphocyte antigens, to hormones, peptides, amines and hormone receptors, to oncofetal antigens, to oncogenes and their products, to cell proliferation antigens, to infectious agents and for the study of glomerular diseases. The practical applications of these antibodies are reviewed with particular emphasis on the use of antibody panels for the identification of anaplastic round cell tumour in adults and children and,of spindle cell neoplasms. Future directions for immunohistochemical techniques include their interphase with molecular biology and their applications in immunoelectron microscopy, in in-situ hybridisation procedures, in automation of routine staining and in image analyses.

Item Type:Journal
Additional Information:We thank Mrs. M. Elemer for her expert secretarial assistance.
Keywords:Diagnostic immunohistochemistry, antibodies, oncogenes, 1ymphocyte typing, automation, in-situ hybridisation.
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:3997

1. Sternberger LA, Hardy PHJ, Cuculis JJ. The unlabelled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horse-radish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. J I-hstochem

Cytochem 1970; 18:3 15.

2. Hsu SM, Raine L, Fanger H. Use of avidinbiotin-

peroxjdase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J fistochem ~ytochem1 981; 29: 577-80.

3. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined origin. Nature 1975; 256: 495-7.

4. Ashall F, Bramwell ME, Harris H. A new marker for human cancer cells. I. The Ca antigen and the Cal antibody. Lancet 1982;2: 1-6

5. McGee JOD, Woods JC, Ashall F, et al. A new marker for human cancer cells. 11. Immunohistochemical detection of the Ca antigen in human tissues with the Cal antibody. Lancet 1982; 2: 7-10.

6. Simpson HW, Candlish W, Liddle C, et al. Experience with the Oxford tumour marker.'Lancet 1983; 1 : 1097.

7. Gabbiani G, Kapancy Y, Baraizone P, Franke W. Immunochemical identification of intermediate sized filaments in human neoplastic cells. Am J Path01 1981; 104: 206-16.

8. Altmannsberger M, Osborn M, Shauer A, Weber K. Antibodies to different intermediate filament proteins. Cell-type specific markers on paraffin-embedded human tissues. Lab Invest 1981; 45: 427-34.

9. Osborn M, Weber K. Tumour diagnosis by intermediate filament typing: A novel tool of surgical pathology.. Lab Invest 1983; 48: 372-94.

10. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. 11. Distribution of filament proteins in normal human tissues. Am J Pathol 1984; 114: 309-21.

11 . Moll R, Frankie WW, Schiller DL. The catalogue of human cytokeratins: Patterns of expression in normal epithelial tumours and cultured cells. Cell 1982; 31:11-24.

12. Cooper D, Schermer A, Sun TT. Classification of human epithelium and their d neoplasms using monoclonal antibodies to keratins: Strategies, applications and 'limitation. Lab Invest 1985; 52: 243-56.

13. Osborn M. Summary: Intermediate filaments 1984. Ann NY Acad Sci 1985; 455: 669-81.

14. McNutt MA, Bolen JW, Gown AM, et al. Coexpression of intermediate filaments in human epithelia1 neoplasms. Ultrastruct Pathol 1985;9: 31-43.

15. Leong ASY. The expression of vimentin in epithelial neoplasms. Prog Surg Pathol 1991; 12: 31-48.

16. Nadji M, Tabei SZ, Castro A, et al. Prostatic origin of tumours. An immunohistochemical study. Am J Clin Pathol 1980; 73: 735-9.

17. Li CY, Lam KW, Yam LT. Immunohistochemical diagnosis of prostatic cancer with metastases. Cancer 1980; 46:706-12.

18. Burgdorf WHC, Mukai K, Rosai J. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged 3 vascular nature. Am J Clin Pathol 1981; 75: 167-71.

19. Guarda LA, Ordonez NG, Smith IL, Hanssen G. Immunoperoxidase localisation of factor VIII in angiosarcomas. Am J Surg Pathol 199 1 (In press).

20. Gown AM, Vogel AM, Hoak D, et al. Monoclonal antibodies specific for melanocytic tumours distinguish subpopulations of melanocytes. Am J Pathol 1986; 123: 195-203.

21. Tsukada T, McNutt MA, Ross R, Gown AM. HHF-35, a muscle actin-specific monoclonal antibody. 11. Reactivity in normal, reactive and neoplastic human tissues. Am J Pathol 1987; 127: 389-94.

22. Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984; 11 5: 458-68.

23. Lloyd RV, Mervak T, Schmidt K, et al. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocr~ne neoplasms. Am J Surg Pathol 1984; 8: 607-14.

24. Backstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol 1983; 7:341 -9.

25. Wick MR, Swanson PE, Manivel JC. Placental-like alkaline phosphatase reactivity in human tumours: An immunohistochemical study of 520 cases. Hum Pathol 1987; 18: 946-954.

26. Forbes IJ, Leong, ASY. Essential Oncology of the Lymphocyte, London: Springer-Verlag 1987.

27. Foon KA, Schroff RW, Gale RP. Surface markers on leukaemia and lymphoma cells: Recent advances. Blood 1982; 60: 1-19.

28. Isaacson PG, Spencer J, Connolly CE, et al. Malignant histiocytosis of the intestine: A T cell lymphoma. Lancet 1985;2: 688-91.

29. Erber WN. Human leucocyte differentiation antigens: Review of CD nomenclature. Pathology 1990; 22: 61 -9.

30. Norton AJ, Isaacson PG. Lyrnphocyte phenotyping in formalinfiied and paraffin wax-embedded tissues. I. Range of antibodies and staining patterns. Histopathology 1989; 14: 437-46.

31. Norton AJ, Isaacson PG. Lymphocyte phenotyping in formalinfixed and paraffin wax-embedded tissues. 11. Profiles of reactivity in the various tumour types. Histopathology 1989; 14: 557-79.

32. Leong ASY, Phillips GE, Pieterse AS, Milios J. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology 1986; 18:393-9.

33. Lippman ME, Allegra JC. Receptors in breast cancer : Oestrogen receptor and endocrine therapy of breast cancer. N

Eng J Med 1978; 299: 930-6.

34. Raymond WA, Leong ASY. The relationship between growth fractions and oestrogen receptors in human breast carcinoma, as determined by immunohistochemical staining. J Pathol 1989; 158: 203-11.

35. Kojiro M, Kawano Y, Isomura T. Distribution of albumin- and/or alphafetoprotein- positive cells in hepatocellular

carcinoma. Lab Invest 1987; 44: 22 1-8.

36. Wick MR, Loy T, Mills SE. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural and irnmunohistologic study of 103 cases. Hum Pathol 1990; 21 : 759-66.

37. Thor A, Ohuchi N, Horan-Hand- P. Ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest 1986; 55: 603-1 5.

38. Candlish W, Kerr IB. Simpson HW. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease. J Pathol 1986; 150: 163-7.

39. Viola MV, Fromowitz F, Oravez S. Expression of ras oncogene p21 in prostate cancer. N Engl J Med 1986; 314: 133-7.

40. 'Thor A. Horan-Hand P, Wunderlich D. monoclonal antibodies define different ras gene expression in malignant and benign colonic diseases. Nature 1984; 311: 562-4.

41. Tahara E, Yasui W, Taniyama K. Ha-ras oncogene production in human gastric carcinoma: Correlation with invasiveness, rnetastases or prognosis. Jpn J Can Res 1986; 77: 5 17-22.

42. Bacus SS, Ruby SG, Weinberg DS. Her- 2/neu oncogene expression and proliferation in breast cancers. Am J Pathol 1990; 137: 103-1 1.

43. Gerdes J, Lernke H, Baisch H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the rnonoclonal antibody IQ-67 J Immunol 1984;133:1710-5.

44. Raymond WA, Long AS-Y, Bolt JW. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol 1988; 156: 161-7.

45. Raymond WA, Leong ASY. Nuclear organiser regions relate to growth fractions in human breast carcinoma. Hum Pathol 1989; 20: 741-6.

46. Garcia RL, Coltera MD, Gown AM. Analysis of proliferative grade using anti- PCNA/cyclin monoclonal antibodies in fmed, embedded sections: Comparison with flowcytometric analysis. Am J Path01 1989; 134: 733-9.

47. Kaye VN. Monoclonal antibodies to microbial antigens in diagnostic pathologv In: Monoclonal antibodies in diagnostic histopathology, Wick MR and Siegal GP (eds). New York: Marcel Dekker, Inc., 1988; p. 623-30.

48. Milios J, Leong ASY, Sutton-Smith P Immunogold-staining of a wide range of tissue antigens in resin-embedded biopsies. Presented at the Annual Scientific Meeting of the Australasian Division of the IAP, Sydney, June, 1991.

49. Leong ASY. Antibody probes in the diagnosis of anaplastic tumours. I. Malignant round cell tumours. Pathology 1986; 18: 296-305.

50. Leong ASY. Immunohistochemistry of anaplastic round cell tumours. In: Immunohistpchemistry Course and Workshop Handout, edited by Leong ASY. Adelaide, South Australia, 1990, p. 72-81.

51. Leong ASY, Parkinson R, Milios J. "Thick" cell membranes revealed by immunocytochemical staining: A clue to the diagnosis of mesothelioma. Diagn Cytopathol 1990; 6: 9-13.

52. Kurtin PJ, Pinkus GS. Leucocyte common antigen - a diagnostic discriminant between haematopoietic and nonhaematopoietic neoplasms in paraffin sections using monoclonal antibodies. Hum Pathol 1985; 16: 353-8.

53. Schmitt FC, Bacchi CE. S100 protein: Is it useful as a tumour marker in diagnostic immunohistochemistry? Histopathology 1989; 15: 281 -8.

54. Leong ASY, Milios J. An assessment of a melanoma-specific antibody (HMB45) and other immunohistochemical markers of malignant melanoma in paraffinembedded tissues. Surg Pathol 1989; 2: 137-45.

55. Leong AS-Y, Kan AE, Milios J. Small round cell tumours in childhood. Immunohistochemical studies in rhabdomyosarcoma, neuroblastoma, Ewing's sarcoma, and lymphoblastic lymphoma. Surg Pathol 1989; 2: 5-17.

56. Jaffe R, Santamaria M, Yunis EJ. The neuroectodermal tumour of bone. Am J Surg Pathol 1984; 8: 885-98.

57. Lipinski M, Braham K, Caillaud JM. HNK-l antibody detects an antigen expressed on neurorectodermal cells. J Exp Med 1983; 158: 1775-80.

58.Leong ASY, Wannakrairot P. A retrospective analysis of immunohistochemical staining in identification of r.

anaplastic round cell and spindle cell tumours - results, reagents and costs. Pathology 1991 (In Press).

59. James CL, Leong AS-Y. Epithelioid leiomyosarcoma of the left atrium: Immunohistochemical and ultrastructural findines. Pathology 1989; 21: 308-13.

60. Fisher C. The value of electron mlcroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: A study of 200 cases. Histopathology 1990; 16: 441 -54.

61. Roholl PJM, deJong ASH, Ramaekers FCS. Applicatjon of markers in the diagnosis of soft tissue tumours. Histopathology 1985; 9: 101 9-35.

62. Raymond WA, Leong ASY. As'sessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology 199 1 (In Press).

63. Ogawa, K, Oguchi M, Yamabe H; et al. Distribution of collagen type IV in soft tissue tumours. An immunohistochemical study. Cancer 1986; 58: 269-77.

64. Grody WW, Cheng L, Lewin KJ. .Application of in-situ DNA hybridisation t technology to diagnostic surgical pathology. Path Ann 1987; 22 (Part 11): 151-75. p.

65. I. Fukushima M, Okagaki T, Twiggs LB. Histological types of carcinoma of the uterine cervix and the detectability of. human papilloma virus DNA. Cancer Res 1985; 45: 3252-5.

66. Yee C, Krishnan-Hewlett I, Baker CC. .Presence and expression of human papilloma virus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361-6.

67. Woodruff JD, Braun L, Cavalieri R. Immunological identification of papilloma virus antigen in paraffin-processed condyloma tissues from the female genital tract. Obstet Gynaecol 1980; 56: 727-32.

68. Brigati DJ, Budgeon LR, Unger ER. Immunocytochemistry is automated: Development of a robotic workstation based on the capillary action principle. J Histotechnol 1988; l1:165-83.

69. McWhinney WHB, Warford A. Rae MJL, Lauder I. Automated imm~lnochemistry. 3 J Clin Path 1990; 43: 591 -6.

70. Leong AS-Y. Commentary: Diagnostic immunohistochemistry - problems and solutions. Pathology 1991 (In press).

Repository Staff Only: item control page
 
 
 
 
 
   
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.